Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 2, 2005, Pages 352-360

  Steiner, Meir ^a,f   Hirschberg, Angelica Lindén ^b   Bergeron, Richard ^c   Holland, Fiona ^d   Gee, Michelle D ^d   Van Erp, Elisabeth ^e  

^a ST JOSEPH S HOSPITAL   (Canada)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d GLAXOSMITHKLINE   (United Kingdom)

^e LEYENBURG HOSPITAL   (Netherlands)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Luteal phase; Paroxetine; Premenstrual dysphoric disorder; Visual analogue scale

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INSOMNIA; LIBIDO DISORDER; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MULTICENTER STUDY; NAUSEA; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUSITIS; SWEATING; TREMOR; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUTEAL PHASE; MIDDLE AGED; PAIN MEASUREMENT; PAROXETINE; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 23844502550     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.01.021     Document Type: Article

References (28)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Press Inc Washington (DC)
2. T.B. Pearlstein, U. Halbreich, E.D. Batzar, C.S. Brown, J. Endicott, and E. Frank Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo J Clin Psychiatry 61 2000 101 109
3. K.A. Yonkers The association between premenstrual dysphoric disorder and other mood disorders J Clin Psychiatry 58 Suppl 15 1997 19 25
4. M. Steiner Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management J Psychiatry Neurosci 25 2000 459 468
5. J. Angst, R. Sellaro, K.R. Merikangas, and J. Endicott The epidemiology of perimenstrual psychological symptoms Acta Psychiatr Scand 104 2001 110 116
6. H.U. Wittchen, E. Becker, R. Lieb, and P. Krause Prevalence, incidence and stability of premenstrual dysphoric disorder in the community Psychol Med 32 2002 119 132
7. M. Steiner, M. Macdougall, and E. Brown The premenstrual symptoms screening tool (PSST) for clinicians Arch Women Ment Health 6 2003 203 209
8. P.W. Dimmock, K.M. Wyatt, P.W. Jones, and P.M. O'Brien Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review Lancet 356 2000 1131 1136
9. T. Pearlstein Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs 62 2002 1869 1885
10. M. Macdougall, and M. Steiner Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety Expert Opin Drug Saf 2 2003 161 166
11. L.S. Cohen, C. Miner, E.W. Brown, E. Freeman, U. Halbreich, and K. Sundell Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries Obstet Gynecol 100 2002 435 444
12. E.W. Freeman, K. Rickels, F. Arredondo, L.C. Kao, S.E. Pollack, and S.J. Sondheimer Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant J Clin Psychopharmacol 19 1999 3 8
13. U. Halbreich, R. Bergeron, K.A. Yonkers, E. Freeman, A.L. Stout, and L. Cohen Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder Obstet Gynecol 100 2002 1219 1229
14. D.M. Jermain, C.K. Preece, R.L. Sykes, T.J. Kuehl, and P.J. Sulak Luteal phase sertraline treatment for premenstrual dysphoric disorder Arch Fam Med 8 1999 328 332
15. M. Steiner, M. Korzekwa, J. Lamont, and A. Wilkins Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria Psychopharmacol Bull 33 1997 771 774
16. C. Sundblad, M.A. Hedberg, and E. Eriksson Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial Neuropsychopharmacology 9 1993 133 145
17. I. Wikander, C. Sundblad, B. Andersch, I. Dagnell, D. Zylberstein, and F. Bengtsson Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 18 1998 390 398
18. S.A. Young, P.H. Hurt, D.M. Benedek, and R.S. Howard Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomised, double-blind, placebo-controlled crossover trial J Clin Psychiatry 59 1998 76 80
19. L.S. Cohen, C.N. Soares, K.A. Yonkers, K.M. Bellew, I.M. Bridges, and M. Steiner Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial Psychosom Med 66 2004 707 713
20. K.A. Yonkers, B.N. Hunter, K.M. Bellew, T.E. Rolfe, M. Steiner, and V.L. Heller Paroxetine controlled release is effective in treating premenstrual dysphoric disorder: a pooled analysis of three trials Obstet Gynecol 101 Suppl 4 2003 110S 111S
21. W. Guy ECDEU Assessment manual for psychopharmacology revised 1976 US Department of Health, Education, and Welfare Washington (DC) Publication ADM 76-338
22. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389
23. M. Steiner, R.F. Haskett, and B.J. Carroll Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales Acta Psychiatr Scand 62 1980 177 190
24. D.V. Sheehan, K. Harnett-Sheehan, and B.A. Raj The measurement of disability Int Clin Psychopharmacol Suppl 3 1996 89 95
25. M. Steiner, D.L. Streiner, S. Steinberg, D. Stewart, D. Carter, and C. Berger The measurement of premenstrual mood symptoms J Affect Disord 53 1999 269 273
26. R. Judge, M.G. Parry, D. Quail, and J.G. Jacobson Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment Int Clin Psychopharmacol 17 2002 217 225
27. D. Michelson, M. Fava, J. Amsterdam, J. Apter, P. Londborg, and R. Tamura Interruption of selective serotonin reuptake inhibitor treatment Br J Psychiatry 176 2000 363 368
28. J.F. Rosenbaum, M. Fava, S.L. Hoog, R.C. Ascroft, and W.B. Krebs Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial Biol Psychiatry 44 1998 77 87